Active Ingredient: DEURUXOLITINIB PHOSPHATE
Proprietary Name: LEQSELVI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 8MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217900
Product Number: 001
Approval Date: Jul 25, 2024
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status:
Prescription
Patent and Exclusivity Information
